Alpelisib for_PIK3CA_-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
作 者
详细资料
相关链接
DOI URL
阿平 的文献笔记 订阅 |
针对PIK3CA突变的HR阳性乳腺癌
PIK3CA抑制剂的的药物效果还不错,延长6个月,反应率提到1/4. |

A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling
Oncogenic Signaling Alters Cell Shape and Mechanics to Facilitate Cell Division under Confinement